A gonadotropin-releasing-hormone antagonist or gonadotropin-releasing-hormone agonist long regimen was used for ovarian stimulation in all patients. When 60% of the follicles reached 16 mm, ovulation was triggered by subcutaneous injection of 250 μg recombinant human choriogonadotropins-ping alfa solution (Merck Serono S.P.A, BA061210). Oocytes were retrieved 34 to 36 hours later and were fertilized by IVF/ICSI. Embryos were in G1-plus/G2-plus media until day 3 or day 5/6 and then transferred into the patient’s uterine cavity. Clinical pregnancy was defined as the presence of a gestational sac with yolk sac, fetal heart, and fetal bud detected by color Doppler ultrasound on the 28th day after ET.